SCHEMBL7740470

SCHEMBL7740470

CCCC1O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)O)O1

nearest known ligand 0.76

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 12/20 0.64
▸ PGR P06401 6/20 0.64
▸ LMNA P02545 3/20 0.64
▸ HIF1A Q16665 3/20 0.64
▸ AR P10275 2/20 0.64
▸ CYP3A4 P08684 1/20 0.64
▸ MAPT P10636 1/20 0.64
▸ HSD17B10 Q99714 1/20 0.64
▸ TDP1 Q9NUW8 1/20 0.64
▸ KDM4E B2RXH2 1/20 0.64
▸ MAPK1 P28482 1/20 0.64
▸ ESR1 P03372 3/20 0.61
▸ ALDH1A1 P00352 1/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ KMT2A Q03164 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8077837 1.00 NR3C1 (0.64) NR3C1PGRLMNAHIF1AAR
SCHEMBL10355183 0.94 NR3C1 (0.62) NR3C1PGRLMNAHIF1AAR
SCHEMBL9478951 0.94 NR3C1 (0.62) NR3C1PGRLMNAHIF1AAR
SCHEMBL7741859 0.94 NR3C1 (0.62) NR3C1PGRLMNAHIF1AAR
SCHEMBL26228034 0.94 NR3C1 (0.65) NR3C1PGRLMNAHIF1AAR
SCHEMBL8135815 0.94 NR3C1 (0.63) NR3C1PGRLMNAHIF1AAR
SCHEMBL5033116 0.93 NR3C1 (0.73) NR3C1PGRLMNAHIF1AAR
SCHEMBL10073752 0.93 NR3C1 (0.73) NR3C1PGRLMNAHIF1AAR
SCHEMBL21153648 0.93 NR3C1 (0.73) NR3C1PGRLMNAHIF1AAR
SCHEMBL21153780 0.93 NR3C1 (0.73) NR3C1PGRLMNAHIF1AAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0502092-B1 ORAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES DRACO AB (SE) 1995-07-26 — — EP claimed
US-6423340-B1 GASTROINTESTINAL DISORDERS, CROHN'S COLITIS AKTIEBOLAGET DRACO (SE) 2002-07-23 — — US disclosed
US-6197761-B1 ANTIINFLAMMATORY, ANTALLERGEN AGENTS GLAXO WELLCOME INC. 2001-03-06 — — US disclosed
EP-0876392-B1 LACTONE DERIVATIVES OF 17.BETA.-CARBOXY, CARBOTHIO AND AMIDE ANDROSTANE DERIVATIVES GLAXO GROUP LTD (GB) 2000-07-05 — — EP disclosed
EP-0876392-A1 LACTONE DERIVATIVES OF 17.BETA.-CARBOXY, CARBOTHIO AND AMIDE ANDROSTANE DERIVATIVES GLAXO GROUP LIMITED (GB) 1998-11-11 — — EP disclosed
WO-1997024365-A1 LACTONE DERIVATIVES OF 17.BETA.-CARBOXY, CARBOTHIO AND AMIDE ANDROSTANE DERIVATIVES GLAXO GROUP LIMITED (GB) 1997-07-10 — — WO disclosed
US-5643602-A TIME RELEASE PELLETS FOR INTESTINES ASTRA AKTIEBOLAG (SE) 1997-07-01 — — US disclosed
EP-0675897-A1 NEW STEROIDS. RHONE POULENC RORER LTD (GB) 1995-10-11 — — EP disclosed
EP-0502092-B1 ORAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES DRACO AB (SE) 1995-07-26 — — EP disclosed
WO-1994014834-A1 NEW STEROIDS RHONE-POULENC RORER LIMITED (GB) 1994-07-07 — — WO disclosed
Send feedback